Growth hormone induces myocardial expression of creatine transporter and decreases plasma levels of IL-1β in rats during early postinfarct cardiac remodeling

Growth Hormone and IGF Research

Volumn 13, Issue 5, 2003, Pages 239-245

  Omerovic, Elmir ^a   Bollano, Entela ^a   Lorentzon, Malin ^a   Walser, Marion ^b   Mattsson Hultén, Lillemor ^a   Isgaard, Jörgen ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adenine nucleotides; Congestive heart failure; Creatine metabolism; Cytokines; Energy metabolism; Growth hormone; Myocardial infarction; Postinfarct remodeling

Indexed keywords

ADENINE; CARRIER PROTEIN; COMPLEMENTARY DNA; CREATINE; CYTOKINE; GROWTH HORMONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; RNA; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENERGY METABOLISM; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY;

EID: 0141832686     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(03)00012-1     Document Type: Article

References (50)

1. L. Sacca, A. Cittadini, S. Fazio, Growth hormone and the heart, Endocr. Rev. 15 (1994) 555-573.
2. B. Merola, A. Cittadini, A. Colao, S. Longobardi, S. Fazio, D. Sabatini, L. Sacca, G. Lombardi, Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency, J. Clin. Endocrinol. Metab. 77 (1993) 1658-1661.
3. H.M. Mather, M.J. Boyd, J.S. Jenkins, Heart size and function in acromegaly, Br. Heart J. 41 (1979) 697-701.
4. S. Fazio, A. Cittadini, B. Biondi, E.A. Palmieri, G. Riccio, F. Bone, U. Oliviero, L. Sacca, Cardiovascular effects of short-term growth hormone hypersecretion, J. Clin. Endocrinol. Metab. 85 (2000) 179-182.
5. R. Yang, S. Bunting, N. Gillett, R.G. Clark, H. Jin, Effects of growth hormone in rats with postinfarction left ventricular dysfunction, Cardiovasc. Drugs Ther. 9 (1995) 125-131.
6. R. Yang, S. Bunting, N. Gillett, R. Clark, H. Jin, Growth hormone improves cardiac performance in experimental heart failure, Circulation 92 (1995) 262-267.
7. S. Fazio, D. Sabatini, B. Capaldo, C. Vigorito, A. Giordano, R. Guida, F. Pardo, B. Biondi, L. Sacca, A preliminary study of growth hormone in the treatment of dilated cardiomyopathy, N. Engl. J. Med. 334 (1996) 809-814.
8. J. Isgaard, C.H. Bergh, K. Caidahl, M. Lomsky, A. Hjalmarson, B.A. Bengtsson, A placebo-controlled study of growth hormone in patients with congestive heart failure, Eur. Heart J. 19 (1998) 1704-1711.
9. K.J. Osterziel, O. Strohm, J. Schuler, M. Friedrich, D. Hanlein, R. Willenbrock, S.D. Anker, P.A. Poole-Wilson, M.B. Ranke, R. Dietz, Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy, Lancet 351 (1998) 1233-1237.
10. J. Takala, E. Ruokonen, N.R. Webster, M.S. Nielsen, D.F. Zandstra, G. Vundelinckx, C.J. Hinds, Increased mortality associated with growth hormone treatment in critically ill adults, N. Engl. J. Med. 341 (1999) 785-792.
11. M. Tajima, E.O. Weinberg, J. Bartunek, H. Jin, R. Yang, N.F. Paoni, B.H. Lorell, Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure, Circulation 99 (1999) 127-134.
12. J. Timsit, B. Riou, J. Bertherat, C. Wisnewsky, N.S. Kato, A.S. Weisberg, J. Lubetzki, Y. Lecarpentier, S. Winegrad, J.J. Mercadier, Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle, J. Clin. Invest. 86 (1990) 507-515.
13. E. Omerovic, E. Bollano, R. Mobini, V. Kujacic, B. Madhu, B. Soussi, M. Fu, A. Hjalmarson, F. Waagstein, J. Isgaard, Growth hormone improves bioenergetics and decreases catecholamines in postinfarct rat hearts, Endocrinology 141 (2000) 4592-4599.
14. H. Selye, E. Bajusz, S. Grasso, P. Mendell, Simple technique for the surgical occlussion of coronary vessels in the rat, Angiology 11 (1960) 398-407.
15. S.E. Litwin, S.E. Katz, J.P. Morgan, P.S. Douglas, Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat, Circulation 89 (1994) 345-354.
16. R.G. Baily, J.C. Lehman, S.S. Gubin, T.I. Musch, Non-invasive assessment of ventricular damage in rats with myocardial infarction, Cardiovasc. Res. 27 (1993) 851-855.
17. P. Chomczynski, N. Sacchi, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162 (1987) 156-159.
18. H. Lee, J.H. Kim, Y.J. Chae, H. Ogawa, M.H. Lee, G.L. Gerton, Creatine synthesis and transport systems in the male rat reproductive tract, Biol. Reprod. 58 (1998) 1437-1444.
19. D.A. Melton, P.A. Krieg, M.R. Rebagliati, T. Maniatis, K. Zinn, M.R. Green, Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter, Nucleic Acids Res. 12 (1984) 7035-7056.
20. D.M. Durnam, R.D. Palmiter, A practical approach for quantitating specific mRNAs by solution hybridization, Anal. Biochem. 131 (1983) 385-393.
21. B. Soussi, K. Lagerwall, J.P. Idstrom, T. Schersten, Purine metabolic pathways in rat hindlimb perfusion model during ischemia and reperfusion, Am. J. Physiol. 265 (1993) H1074-H1081.
22. J.M. Pfeffer, M.A. Pfeffer, P.J. Fletcher, E. Braunwald, Ventricular performance in rats with myocardial infarction and failure, Am. J. Med. 76 (1984) 99-103.
23. W. Mayser, P. Schloss, H. Betz, Primary structure and functional expression of a choline transporter expressed in the rat nervous system, FEBS Lett. 305 (1992) 31-36.
24. N.S. Dhalla, D. Kaura, X. Liu, R.E. Beamish, Mechanisms of subcellular remodelling in postinfarct heart failure, Exs 76 (1996) 463-477.
25. G.S. Francis, K. McDonald, C. Chu, J.N. Cohn, Pathophysiologic aspects of end-stage heart failure, Am. J. Cardiol. 75 (1995) 11A-16A.
26. J.J. Hwang, V.J. Dzau, C.C. Liew, Genomics and the pathophysiology of heart failure, Curr. Cardiol. Rep. 3 (2001) 198-207.
27. L. Nascimben, J.S. Ingwall, P. Pauletto, J. Friedrich, J.K. Gwathmey, V. Saks, A.C. Pessina, P.D. Allen, Creatine kinase system in failing and nonfailing human myocardium, Circulation 94 (1996) 1894-1901 (0009-7322).
28. J.S. Ingwall, W. Shen, The chemistry of the ATP in the failing heart, Heart Fail. Rev. 4 (1999) 221-228.
29. J.S. Ingwall, Do changes in the creatine kinase system contribute to ventricular dysfunction in the filing heart?, in: Current and Future Applications of Magnetic Resonance in Cardiovascular Disease, Futura Publishing Company, Inc, 1998, pp. 447-458.
30. J.S. Ingwall, Is cardiac failure a consequence of decreased energy reserve?, Circulation 87 (1993) VII-58-VII-62.
31. S. Neubauer, H. Remkes, M. Spindler, M. Horn, F. Wiesmann, J. Prestle, B. Walzel, G. Ertl, G. Hasenfuss, T. Wallimann, Downregulation of the Na(+)-creatine cotransporter in failing human myocardium and in experimental heart failure, Circulation 100 (1999) 1847-1850.
32. J.S. Ingwall, D.E. Atkinson, K. Clarke, J.K. Fetters, Energetic correlates of cardiac failure: changes in the creatine kinase system in the failing myocardium, Eur. Heart J. 11 (Suppl. B) (1990) 108-115 (0195-668X).
33. J.S. Ingwall, M.F. Kramer, M.A. Fifer, B.H. Lorell, R. Shemin, W. Grossman, P.D. Allen, The creatine kinase system in normal and diseased human myocardium, N. Engl. J. Med. 313 (1985) 1050-1054.
34. B. Walzel, O. Speer, E. Boehm, S. Kristiansen, S. Chan, K. Clarke, J.P. Magges, E.A. Richter, T. Wallimann, New creatine transporter assay and identification of distinct creatine transporter isoforms in muscle, Am. J. Physiol. Endocrinol. Metab. 283 (2002) E390-E401.
35. T.A. Brannon, G.R. Adams, C.L. Conniff, K.M. Baldwin, Effects of creatine loading and training on running performance and biochemical properties of rat skeletal muscle, Med. Sci. Sports Exerc. 29 (1997) 489-495.
36. S. Neubauer, M. Hom, A. Naumann, R. Tian, K. Hu, M. Laser, J. Friedrich, P. Gaudron, K. Schnackerz, J.S. Ingwall, et al., Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction, J. Clin. Invest. 95 (1995) 1092-1100.
37. K.C. Wollert, H. Drexler, The role of interleukin-6 in the failing heart, Heart Fail. Rev. 6 (2001) 95-103.
38. C.S. Long, The role of interleukin-1 in the failing heart, Heart Fail. Rev. 6 (2001) 81-94.
39. D.L. Mann, Recent insights into the role of tumor necrosis factor in the failing heart, Heart Fail. Rev. 6 (2001) 71-80.
40. G. Torre-Amione, S. Kapadia, C. Benedict, H. Oral, J.B. Young, D.L. Mann, Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD), J. Am. Coll. Cardiol. 27 (1996) 1201-1206.
41. Y. Wada, M. Sato, M. Niimi, M. Tamaki, T. Ishida, J. Takahara, Inhibitory effects of interleukin-1 on growth hormone secretion in conscious male rats, Endocrinology 136 (1995) 3936-3941.
42. D. Grimm, D. Cameron, D.P. Griese, G.A. Riegger, E.P. Kromer, Differential effects of growth hormone on cardiomyocyte and extracellular matrix protein remodeling following experimental myocardial infarction, Cardiovasc. Res. 40 (1998) 297-306.
43. A. Bruel, H. Oxlund, The effect of growth hormone on rat myocardial collagen, Growth Horm. IGF Res. 9 (1999) 123-130.
44. T. Gulick, M.K. Chung, S.J. Pieper, L.G. Lange, G.F. Schreiner, Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness, Proc. Natl. Acad. Sci. USA 86 (1989) 6753-6757.
45. B.S. Cain, D.R. Meldrum, C.A. Dinarello, X. Meng, K.S. Joo, A. Banerjee, A.H. Harken, Tumor necrosis factor-α and interleukin-1β synergistically depress human myocardial function, Crit. Care Med. 27 (1999) 1309-1318.
46. Q. He, M.C. LaPointe, Interleukin-1β regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes, Hypertension 33 (1999) 283-289.
47. C.M. Thaik, A. Calderone, N. Takahashi, W.S. Colucci, Interleukin-1β modulates the growth and phenotype of neonatal rat cardiac myocytes, J. Clin. Invest. 96 (1995) 1093-1099.
48. C.F. McTiernan, B.H. Lemster, C. Frye, S. Brooks, A. Combes, A.M. Feldman, Interleukin-1β inhibits phospholamban gene expression in cultured cardiomyocytes, Circ. Res. 81 (1997) 493-503.
49. 2+ transients and adenylate cyclase activity, Am. J. Physiol. 272 (1997) H1937-H1944.
50. Q. He, M.C. LaPointe, Interleukin-1β regulates the human brain natriuretic peptide promoter via Ca(2+)-dependent protein kinase pathways, Hypertension 35 (2000) 292-296.